M. C. Castells, L. B. Klickstein, K. Hassani, Cumplido J.A., M. E. Lacouture, K. F. Austen, and H. R. Katz. gp49B1-alpha(v) beta(3) interaction inhibits antigen-induced mast cell activation. Nature Immunol. 2:436-442, 2001.
M. Daheshia, D. S. Friend, M. J. Grusby, K. F. Austen, and H. R. Katz. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J.Exp.Med. 194:227-233, 2001.
J. S. Zhou, D. S. Friend, A. F. Feldweg, M. Daheshia, L. Li, K. F. Austen, and H. R. Katz. Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: Evidence for an important role for gp49B1 expression on neutrophils. J.Exp.Med. 198:1243-1251, 2003.
J. S. Zhou, W. Xing, D. S. Friend, K. F. Austen, and H. R. Katz. Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis. J.Exp.Med. 204 (12):2797-2802, 2007.
R. G. Breslow, J. J. Rao, W. Xing, D. I. Hong, N. A. Barrett, and H. R. Katz. Inhibition of Th2 adaptive immune responses and pulmonary inflammation by leukocyte Ig-like receptor B4 on dendritic cells. J.Immunol. 184:1003-1013, 2010.